Drug therapy of portal hypertension

Groszmann, R.J.

American Journal of Gastroenterology 82(2): 107-113

1987


ISSN/ISBN: 0002-9270
PMID: 3544812
Document Number: 303511
Portal hypertension is the result of increased flow and increased resistance in the portal system. Pharmacological therapy is aimed at altering these factors by the use of vasoconstrictors to reduce flow and vasodilators to decrease intrahepatic resistance. The current status of pharmacological agents to achieve these effects is reviewed.

Document emailed within 1 workday
Secure & encrypted payments